BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 22512636)

  • 1. Particle-mediated delivery of cytokines for immunotherapy.
    Christian DA; Hunter CA
    Immunotherapy; 2012 Apr; 4(4):425-41. PubMed ID: 22512636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paracrine cytokine adjuvants in cancer immunotherapy.
    Pardoll DM
    Annu Rev Immunol; 1995; 13():399-415. PubMed ID: 7612229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineering Protein Delivery Depots for Cancer Immunotherapy.
    Wen D; Chen G; Chen Q; Li PY; Cheng H; Gu Z
    Bioconjug Chem; 2019 Mar; 30(3):515-524. PubMed ID: 30839198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The potential of nanoparticle vaccines as a treatment for cancer.
    Urbanavicius D; Alvarez T; Such GK; Johnston APR; Mintern JD
    Mol Immunol; 2018 Jun; 98():2-7. PubMed ID: 29395251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokine, chemokine, and co-stimulatory fusion proteins for the immunotherapy of solid tumors.
    Khawli LA; Hu P; Epstein AL
    Handb Exp Pharmacol; 2008; (181):291-328. PubMed ID: 18071951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delivery technologies for cancer immunotherapy.
    Riley RS; June CH; Langer R; Mitchell MJ
    Nat Rev Drug Discov; 2019 Mar; 18(3):175-196. PubMed ID: 30622344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineered Nanoparticles for Cancer Vaccination and Immunotherapy.
    Aikins ME; Xu C; Moon JJ
    Acc Chem Res; 2020 Oct; 53(10):2094-2105. PubMed ID: 33017150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug Delivery for Cancer Immunotherapy and Vaccines.
    Batty CJ; Tiet P; Bachelder EM; Ainslie KM
    Pharm Nanotechnol; 2018; 6(4):232-244. PubMed ID: 30227827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer Vaccine Immunotherapy with RNA-Loaded Liposomes.
    Sayour EJ; Mendez-Gomez HR; Mitchell DA
    Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30249040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoengineering approaches for cytokine therapy.
    Mansurov A; Lauterbach A; Budina E; Alpar AT; Hubbell JA; Ishihara J
    Am J Physiol Cell Physiol; 2021 Aug; 321(2):C369-C383. PubMed ID: 34232748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combinational adenovirus-mediated gene therapy and dendritic cell vaccine in combating well-established tumors.
    Xia D; Moyana T; Xiang J
    Cell Res; 2006 Mar; 16(3):241-59. PubMed ID: 16541123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Part II: targeted particles for imaging of anticancer immune responses.
    Hung RW; Hamdy S; Haddadi A; Ghotbi Z; Lavasanifar A
    Curr Drug Deliv; 2011 May; 8(3):274-81. PubMed ID: 21291375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Micro- and nanoparticulates for DNA vaccine delivery.
    Farris E; Brown DM; Ramer-Tait AE; Pannier AK
    Exp Biol Med (Maywood); 2016 May; 241(9):919-29. PubMed ID: 27048557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel Granzyme B nanoparticle delivery system simulates immune cell functions for suppression of solid tumors.
    Qian X; Shi Z; Qi H; Zhao M; Huang K; Han D; Zhou J; Liu C; Liu Y; Lu Y; Yuan X; Zhao J; Kang C
    Theranostics; 2019; 9(25):7616-7627. PubMed ID: 31695790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delivery strategies of cancer immunotherapy: recent advances and future perspectives.
    Zhao Z; Zheng L; Chen W; Weng W; Song J; Ji J
    J Hematol Oncol; 2019 Nov; 12(1):126. PubMed ID: 31779642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of polymeric nanoparticles in immunotherapy.
    Craparo EF; Bondì ML
    Curr Opin Allergy Clin Immunol; 2012 Dec; 12(6):658-64. PubMed ID: 23095912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liposomes and nanotechnology in drug development: focus on oncotargets.
    Kozako T; Arima N; Yoshimitsu M; Honda SI; Soeda S
    Int J Nanomedicine; 2012; 7():4943-51. PubMed ID: 23028222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cascade Cytosol Delivery of Dual-Sensitive Micelle-Tailored Vaccine for Enhancing Cancer Immunotherapy.
    Jiang D; Mu W; Pang X; Liu Y; Zhang N; Song Y; Garg S
    ACS Appl Mater Interfaces; 2018 Nov; 10(44):37797-37811. PubMed ID: 30360105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting cytokines to tumors to induce active antitumor immune responses by recombinant fusion proteins.
    Xiang J
    Hum Antibodies; 1999; 9(1):23-36. PubMed ID: 10331183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokines and antitumor immunity.
    Müller L; Pawelec G
    Technol Cancer Res Treat; 2003 Jun; 2(3):183-94. PubMed ID: 12779349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.